Update on diabetes mellitus: prevention, treatment, and association with oral diseases
Diabetes mellitus is a prevalent disease that affects millions of people worldwide and has paralleled the growing population of overweight and obese individuals. Early detection of prediabetes and diabetes, as well as lifestyle interventions including diet and exercise, are the overarching objective...
Saved in:
| Published in | Oral diseases Vol. 14; no. 2; pp. 105 - 114 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.03.2008
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Diabetes mellitus is a prevalent disease that affects millions of people worldwide and has paralleled the growing population of overweight and obese individuals. Early detection of prediabetes and diabetes, as well as lifestyle interventions including diet and exercise, are the overarching objectives in preventing and managing diabetes. For individuals who do not achieve glycemic control with lifestyle modification, there are newer medication classes that assist with weight loss, more physiologic insulins with convenient delivery systems, and old standbys like metformin and thiazolidinediones. Glycemic control along with blood pressure and cholesterol management reduce microvascular and macrovascular disease including cardiovascular events.
Mounting evidence demonstrates that diabetes is a risk factor for periodontitis and possibly oral premalignancies and oral cancer. The systemic inflammatory response generated by inflamed periodontal tissue may in turn exacerbate diabetes, worsen cardiovascular outcomes, and increase mortality. Thus, oral medical and surgical physicians are vital in treating oral pathology, recognizing new cases of diabetes, and counseling people with diabetes to promote oral health. This article presents updates in the diagnosis, risk factors, prevention, management, and peri‐oral complications of diabetes to assist oral health professionals in providing optimal care to patients with diabetes. |
|---|---|
| AbstractList | Diabetes mellitus is a prevalent disease that affects millions of people worldwide and has paralleled the growing population of overweight and obese individuals. Early detection of prediabetes and diabetes, as well as lifestyle interventions including diet and exercise, are the overarching objectives in preventing and managing diabetes. For individuals who do not achieve glycemic control with lifestyle modification, there are newer medication classes that assist with weight loss, more physiologic insulins with convenient delivery systems, and old standbys like metformin and thiazolidinediones. Glycemic control along with blood pressure and cholesterol management reduce microvascular and macrovascular disease including cardiovascular events. Mounting evidence demonstrates that diabetes is a risk factor for periodontitis and possibly oral premalignancies and oral cancer. The systemic inflammatory response generated by inflamed periodontal tissue may in turn exacerbate diabetes, worsen cardiovascular outcomes, and increase mortality. Thus, oral medical and surgical physicians are vital in treating oral pathology, recognizing new cases of diabetes, and counseling people with diabetes to promote oral health. This article presents updates in the diagnosis, risk factors, prevention, management, and peri-oral complications of diabetes to assist oral health professionals in providing optimal care to patients with diabetes. Diabetes mellitus is a prevalent disease that affects millions of people worldwide and has paralleled the growing population of overweight and obese individuals. Early detection of prediabetes and diabetes, as well as lifestyle interventions including diet and exercise, are the overarching objectives in preventing and managing diabetes. For individuals who do not achieve glycemic control with lifestyle modification, there are newer medication classes that assist with weight loss, more physiologic insulins with convenient delivery systems, and old standbys like metformin and thiazolidinediones. Glycemic control along with blood pressure and cholesterol management reduce microvascular and macrovascular disease including cardiovascular events. Mounting evidence demonstrates that diabetes is a risk factor for periodontitis and possibly oral premalignancies and oral cancer. The systemic inflammatory response generated by inflamed periodontal tissue may in turn exacerbate diabetes, worsen cardiovascular outcomes, and increase mortality. Thus, oral medical and surgical physicians are vital in treating oral pathology, recognizing new cases of diabetes, and counseling people with diabetes to promote oral health. This article presents updates in the diagnosis, risk factors, prevention, management, and peri‐oral complications of diabetes to assist oral health professionals in providing optimal care to patients with diabetes. |
| Author | Skamagas, M LeRoith, D Breen, TL |
| Author_xml | – sequence: 1 givenname: M surname: Skamagas fullname: Skamagas, M organization: Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, New York, NY, USA – sequence: 2 givenname: TL surname: Breen fullname: Breen, TL organization: Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, New York, NY, USA – sequence: 3 givenname: D surname: LeRoith fullname: LeRoith, D organization: Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, New York, NY, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18302671$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkEtPHDEQhC1ExCv5C8gnTsymbY_tmUgcEAmEBIVLSBAXy57pVbzMY7G9Yfn38WRX5BpfXFZXVVvfIdkdxgEJoQxmLJ_3ixlTwAqouJxxAD0DVma53iEHr4PdrIUsC8nF_T45jHEBwHQt-B7ZZ5UArjQ7ID_ulq1NSMeBtt46TBhpj13n0yp-oMuAv3FIfhxOaQpoU59fp9QOLbUxjo2304w--_SLjsF2uSOijRjfkjdz20V8t72PyN3lp-8Xn4ub26vri_OboilByqJuaybnILlzVaNZDUpp2bS8rCxHZ6FsHLiSq5a7RlUVE4jzWjnZKlVrIaU4Iieb3mUYn1YYk-l9bPL_7YDjKhoNQqiSTcZqY2zCGGPAuVkG39vwYhiYialZmAmdmdCZian5y9Ssc_R4u2Plemz_BbcQs-FsY3j2Hb78d7G5_Xg9qZwvNnkfE65f8zY8GqWFlubntyvzVbL7y4cazBfxBxUPle8 |
| CitedBy_id | crossref_primary_10_1007_s00108_011_2835_2 crossref_primary_10_1016_S0718_5391_12_70096_4 crossref_primary_10_1902_jop_2009_090414 crossref_primary_10_1111_jre_12536 crossref_primary_10_2217_fmb_13_30 crossref_primary_10_1002_JPER_20_0048 crossref_primary_10_1186_s12889_020_08673_x crossref_primary_10_4155_tde_2017_0042 crossref_primary_10_26693_jmbs03_04_013 crossref_primary_10_1016_j_micpath_2018_11_028 crossref_primary_10_1016_j_archoralbio_2020_104883 crossref_primary_10_1016_j_bioorg_2022_106276 crossref_primary_10_1016_j_diabres_2011_01_011 crossref_primary_10_1016_j_pdpdt_2022_102972 crossref_primary_10_3389_fdmed_2021_670012 crossref_primary_10_1055_a_1286_8376 crossref_primary_10_14219_jada_archive_2012_0014 crossref_primary_10_5897_JDOH2017_0219 crossref_primary_10_1007_s12548_008_0011_7 crossref_primary_10_1155_2016_5048967 crossref_primary_10_1016_j_joms_2013_10_010 crossref_primary_10_7243_2055_7205_1_1 crossref_primary_10_1111_j_1601_0825_2009_01584_x crossref_primary_10_3109_00016357_2014_898789 crossref_primary_10_56984_8ZG141475 crossref_primary_10_5005_JP_Journals_10012_1089 crossref_primary_10_1016_j_archoralbio_2017_10_009 crossref_primary_10_1016_j_jds_2013_10_006 crossref_primary_10_1016_j_bios_2021_113237 crossref_primary_10_2460_javma_238_5_601 crossref_primary_10_1007_s12614_010_0832_9 crossref_primary_10_1016_j_ajodo_2010_06_021 crossref_primary_10_20515_otd_771272 crossref_primary_10_1021_acsbiomaterials_4c00161 crossref_primary_10_1016_j_jsb_2016_09_007 crossref_primary_10_1016_j_bmcl_2017_04_078 crossref_primary_10_1177_0164027514537082 crossref_primary_10_1093_fampra_cms034 crossref_primary_10_2478_bjdm_2018_0002 crossref_primary_10_2337_dc09_1262 crossref_primary_10_1016_j_cden_2013_01_004 crossref_primary_10_1016_j_jsps_2018_02_029 crossref_primary_10_1016_j_pdpdt_2021_102350 crossref_primary_10_1186_s12913_018_3321_5 crossref_primary_10_1016_j_foodres_2023_113163 crossref_primary_10_1371_journal_pone_0093377 crossref_primary_10_1016_j_molstruc_2021_131260 crossref_primary_10_1016_j_jphotobiol_2014_03_023 crossref_primary_10_1038_sj_bdj_2011_769 crossref_primary_10_1080_10520295_2020_1718756 crossref_primary_10_1016_j_ejbas_2016_12_002 crossref_primary_10_1021_acs_jmedchem_6b00505 crossref_primary_10_1186_s12903_023_03337_9 crossref_primary_10_4103_ijpvm_IJPVM_520_17 crossref_primary_10_1021_acsfoodscitech_3c00102 crossref_primary_10_1177_1932296820930287 crossref_primary_10_3402_ljm_v6i0_5691 crossref_primary_10_1111_adj_12288 crossref_primary_10_1111_ajag_12326 crossref_primary_10_3390_ijerph19094995 crossref_primary_10_1002_JPER_18_0140 |
| Cites_doi | 10.1034/j.1600-0528.2001.290305.x 10.2337/diacare.27.3.770 10.1902/jop.1996.67.10s.1085 10.1111/j.1600-051X.2006.01002.x 10.1034/j.1600-051x.2001.028004306.x 10.1902/jop.2003.74.9.1361 10.1056/NEJM199309303291401 10.1056/NEJMoa073394 10.1056/NEJMoa072761 10.2337/diabetes.51.9.2796 10.1056/NEJMoa066224 10.1056/NEJMoa011300 10.1172/JCI117433 10.1016/j.oraloncology.2006.02.004 10.2337/diab.23.1.9 10.2337/diacare.20.4.537 10.1111/j.1600-051X.1988.tb01003.x 10.1136/bmj.321.7258.412 10.1016/S0140-6736(98)04311-6 10.1902/jop.1997.68.8.713 10.1177/00220345010800020201 10.1016/S0140-6736(03)13636-7 10.2337/diabetes.46.5.742 10.1902/jop.2000.71.10.1528 10.1056/NEJMoa052187 10.2337/diacare.29.03.06.dc05-1254 10.1210/jc.86.7.3257 10.1016/S0140-6736(02)08905-5 10.1056/NEJMoa012512 10.1001/jama.287.19.2563 10.2337/diacare.22.2.233 10.1111/j.1601-0825.2005.01119.x 10.1034/j.1600-0528.2002.300304.x 10.1056/NEJM200105033441801 10.1210/jc.87.3.1419 10.2337/diacare.16.1.329 10.1007/s00134-002-1628-4 10.1016/S0140-6736(06)69705-5 10.1016/S0140-6736(06)69420-8 10.2337/diacare.27.6.1265 10.1016/S0003-4975(99)00014-4 10.2337/diacare.28.1.27 10.1111/j.1601-0825.1998.tb00253.x 10.1046/j.1464-5491.2001.00509.x 10.1016/S1557-0843(07)80061-3 10.2337/diacare.28.9.2130 10.1016/j.jacc.2006.08.053 10.2337/diacare.28.9.2093 10.1056/NEJMoa050461 10.2337/dc05-2101 10.1046/j..2003.com122.x 10.7326/0003-4819-141-6-200409210-00007 10.1001/jama.290.14.1884 10.1001/jama.298.2.194 10.1136/bmj.317.7160.703 |
| ContentType | Journal Article |
| Copyright | 2008 The Authors |
| Copyright_xml | – notice: 2008 The Authors |
| DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1111/j.1601-0825.2007.01425.x |
| DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Dentistry |
| EISSN | 1601-0825 |
| EndPage | 114 |
| ExternalDocumentID | 10_1111_j_1601_0825_2007_01425_x 18302671 ODI1425 ark_67375_WNG_K51XFZ90_J |
| Genre | reviewArticle Journal Article Review |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 29N 31~ 33P 34H 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CWXXS D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EBD EBS EJD F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WBNRW WIH WIJ WIK WOHZO WPGGZ WQJ WRC WXI WXSBR XG1 YFH ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c4055-9d915f052bb8c71906675cd248a2eba04cb0b426d2bc68813eef96b5d66973553 |
| IEDL.DBID | DR2 |
| ISSN | 1354-523X |
| IngestDate | Fri Aug 16 21:04:22 EDT 2024 Fri Aug 23 00:48:59 EDT 2024 Sat Sep 28 07:45:11 EDT 2024 Sat Aug 24 00:59:04 EDT 2024 Wed Oct 30 09:50:59 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4055-9d915f052bb8c71906675cd248a2eba04cb0b426d2bc68813eef96b5d66973553 |
| Notes | istex:748042A136BE1C9F1C0302A1FADA5E86FE6A230C ark:/67375/WNG-K51XFZ90-J ArticleID:ODI1425 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| PMID | 18302671 |
| PQID | 70336415 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_70336415 crossref_primary_10_1111_j_1601_0825_2007_01425_x pubmed_primary_18302671 wiley_primary_10_1111_j_1601_0825_2007_01425_x_ODI1425 istex_primary_ark_67375_WNG_K51XFZ90_J |
| PublicationCentury | 2000 |
| PublicationDate | 2008-03 March 2008 2008-Mar 2008-03-00 20080301 |
| PublicationDateYYYYMMDD | 2008-03-01 |
| PublicationDate_xml | – month: 03 year: 2008 text: 2008-03 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Denmark |
| PublicationTitle | Oral diseases |
| PublicationTitleAlternate | Oral Dis |
| PublicationYear | 2008 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | Home PD, Pocock SJ, Beck-Nielsen H et al (2007). Rosiglitazone evaluated for cardiovascular outcomes - an interim analysis. N Engl J Med 357: 28-38. Emslie-Smith AM, Boyle DIR, Evans JMM, Sullivan F, Morris AD (2001). Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines. Diabet Med 18: 483-488. Resnick HE, Foster GL, Bardsley J, Ratner RE (2006). Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 29: 531-537. Dandona P, Aljada A, Mohanty P et al (2001). Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86: 3257-3265. Hansson L, Zanchetti A, Carruthers SG et al (1998). Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351: 1755-1762. Rosenstock J, Hassman DR, Madder RD et al (2004). Repaglinide versus nateglinide monotherapy: a randomized, multicenter study. Diabetes Care 27: 1265-1270. Saremi A, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW, Shlossman M, Bennett PH, Genco R, Knowler WC (2005). Periodontal disease and mortality in type 2 diabetes. Diabetes Care 28: 27-32. Taylor GW, Burt BA, Becker MP et al (1996). Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 67: 1085-1093. Adler AI, Stratton IM, Neil HA et al (2000). Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321: 412-419. Grossi SG, Skrepcinski FB, DeCaro T et al (1997). Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 68: 713-719. Perner A, Nielsen SE, Rask-Madsen J (2003). High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 29: 642-645. Fourlanos S, Perry C, Stein MS, Stankovich J, Harrison LC, Colman PG (2006). A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care 29: 970-975. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, Van Der Velden U (2000). Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71: 1528-1534. Drucker DJ, Nauck MA (2006). The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368: 1696-1705. Writing Team for the DCCT / EDIC Research group (2002). Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287: 2563-2569. Salpeter S, Greyber E, Pasternak G, Salpeter E (2006). Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 1: CD002967. Trovati M, Anfossi G, Massucco P et al (1997). Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-30, 50-cyclic monophosphate and adenosine-30, 50-cyclic monophosphate. Diabetes 46: 742-749. Worthley MI, Holmes AS, Willoughby SR et al (2007). The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes: mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardiol 49: 304-310. Roglic G, Unwin N, Bennett PH et al (2005). The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28: 2130-2135. Standards of Medical Care in Diabetes (2007). American Diabetes Association. Diabetes Care 30: S4-S41. Goutzanis L, Vairaktaris E, Yapijakis C et al (2007). Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. Oral Oncol 43: 165-173. Petrou-Amerikanou C, Markopoulos AK, Belazi M, Karamitsos D, Papanayotou P (1998). Prevalence of oral lichen planus in diabetes mellitus according to the type of diabetes. Oral Dis 4: 37-40. Rodrigues DC, Taba MJ, Novaes AB, Souza SL, Grisi MF (2003). Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol 74: 1361-1367. Aljada A, Ghanim H, Mohanty P, Kapur N, Dandona P (2002). Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 87: 1419-1422. Bagdade JD, Root RK, Bulger RJ (1974). Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 23: 9-15. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002). Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 359: 2072-2077. Ujpa′l M, Matos O, Bı′bok G, Somogyi A, Szabo′ G, Suba Z (2004). Diabetes and oral tumors in Hungary. Epidemiological correlations. Diabetes Care 27: 770-774. Kahn SE, Haffner SM, Heise MA et al (2006). Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355: 2427-2443. The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone medication) Investigators (2006). Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 368: 1096-1105. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group (1999). Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 354: 617-621. Sheiham A, Steele JG, Marcenes W et al (2001b). The relationship among dental status, nutrient intake, and nutritional status in older people. J Dent Res 80: 408-413. Stewart JE, Wager KA, Friedlander AH, Zadeh HH (2001). The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol 28: 306-310. Tuomilehto J, Lindstrom J, Eriksson JG et al (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350. Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999). The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233-240. Pan XR, Li GW, Hu YH et al (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-544. Collins R, Armitage J, Parish S, Sleigh P, Peto R (2003). Heart Protection Collaborative Group. MRC / BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361: 2005-2016. Promsudthi A, Pimapansri S, Deerochanawong C, Kanchanavasita W (2005). The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects. Oral Dis 11: 293-298. Amori RE, Lau J, Pittas AG (2007). Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 298: 194-206. Buchanan TA, Xiang AH, Peters RK et al (2002). Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51: 2796-2803. LaRosa JC, Grundy SM, Waters DD et al (2005). Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352: 1425-1435. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF (2003). Lifetime risk for diabetes mellitus in the United States. JAMA 290: 1884-1890. Magnotti MA, Rayfield EJ (2007). An update on insulin injection devices. Insulin 2: 173-181. Löe H (1993). Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care 16: 329-334. UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A (1999). Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67: 352-360. Selvin E, Marinopoulos S, Berkenblit G et al (2004). Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141: 421-431. UK Prospective Diabetes Study (UKPDS) Group (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: (UKPDS 38). BMJ 317: 703-713. Van Den Berghe G, Wouters P, Weekers F et al (2001). Intensive insulin therapy in critically ill patients. N Engl J Med 345: 1359-1367. Gerich J, Raskin P, Jean-Louis L, Purkayastha D, Baron A (2005). PRESERVE: two year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin. Diabetes Care 28: 2093-2100. Nissen SE, Wolski K (2007). Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457-2471. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD (1994). Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172-1179. Allen PF, McMillan AS (2003). A review of the functional and psychosocial out 2001; 344 1993; 329 2004; 27 2002; 51 1997; 46 2002; 359 1998; 317 2007; 30 1998; 352 2005; 28 2007; 34 2001; 345 2001; 86 1998; 351 2001a; 29 2007; 298 2002; 87 2006; 29 2002; 346 2007; 2 2000; 321 2001; 18 2006; 368 1996; 67 2003; 361 2005; 352 2002; 30 2005; 353 1997; 20 2004; 141 1997; 68 1999; 67 1999; 22 2000; 71 2003; 290 2004 2006; 1 2001; 28 2003; 74 2003; 31 2001b; 80 2006; 355 2007; 356 2007; 357 1974; 23 1993; 16 2002; 287 2003; 69 2003; 29 1999; 354 2007; 43 1994; 94 1998; 4 2005; 11 2007; 49 Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group (e_1_2_15_17_1) 1999; 354 e_1_2_15_21_1 e_1_2_15_42_1 e_1_2_15_40_1 Salpeter S (e_1_2_15_41_1) 2006; 1 e_1_2_15_3_1 e_1_2_15_29_1 e_1_2_15_27_1 e_1_2_15_48_1 e_1_2_15_61_1 The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone medication) Investigators (e_1_2_15_52_1) 2006; 368 e_1_2_15_25_1 e_1_2_15_23_1 e_1_2_15_44_1 e_1_2_15_9_1 Allen PF (e_1_2_15_4_1) 2003; 69 e_1_2_15_7_1 e_1_2_15_5_1 Tataranni PA (e_1_2_15_49_1) 2004 UK Prospective Diabetes Study (UKPDS) Group (e_1_2_15_58_1) 1998; 317 e_1_2_15_10_1 e_1_2_15_31_1 e_1_2_15_56_1 e_1_2_15_18_1 e_1_2_15_39_1 e_1_2_15_16_1 e_1_2_15_37_1 e_1_2_15_50_1 e_1_2_15_14_1 e_1_2_15_35_1 e_1_2_15_12_1 e_1_2_15_33_1 e_1_2_15_54_1 e_1_2_15_19_1 e_1_2_15_20_1 e_1_2_15_43_1 e_1_2_15_28_1 e_1_2_15_2_1 e_1_2_15_26_1 e_1_2_15_60_1 e_1_2_15_24_1 e_1_2_15_47_1 e_1_2_15_22_1 e_1_2_15_45_1 e_1_2_15_8_1 e_1_2_15_6_1 e_1_2_15_32_1 e_1_2_15_55_1 e_1_2_15_30_1 e_1_2_15_57_1 e_1_2_15_59_1 e_1_2_15_15_1 e_1_2_15_38_1 e_1_2_15_13_1 e_1_2_15_36_1 e_1_2_15_51_1 Standards of Medical Care in Diabetes (e_1_2_15_46_1) 2007; 30 e_1_2_15_11_1 e_1_2_15_34_1 e_1_2_15_53_1 |
| References_xml | – volume: 68 start-page: 713 year: 1997 end-page: 719 article-title: Treatment of periodontal disease in diabetics reduces glycated hemoglobin publication-title: J Periodontol – volume: 87 start-page: 1419 year: 2002 end-page: 1422 article-title: Insulin inhibits the pro‐inflammatory transcription factor early growth response gene‐1 (Egr)‐1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor‐1 (PAI‐1) concentrations publication-title: J Clin Endocrinol Metab – volume: 29 start-page: 195 year: 2001a end-page: 203 article-title: Prevalence of impacts of dental and oral disorders and their effects on eating among older people; a national survey in Great Britain publication-title: Community Dent Oral Epidemiol – volume: 351 start-page: 1755 year: 1998 end-page: 1762 article-title: Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group publication-title: Lancet – volume: 29 start-page: 531 year: 2006 end-page: 537 article-title: Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999–2002: the National Health and Nutrition Examination Survey publication-title: Diabetes Care – volume: 29 start-page: 642 year: 2003 end-page: 645 article-title: High glucose impairs superoxide production from isolated blood neutrophils publication-title: Intensive Care Med – volume: 94 start-page: 1172 year: 1994 end-page: 1179 article-title: Insulin‐mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release publication-title: J Clin Invest – volume: 28 start-page: 2130 year: 2005 end-page: 2135 article-title: The burden of mortality attributable to diabetes: realistic estimates for the year 2000 publication-title: Diabetes Care – volume: 51 start-page: 2796 year: 2002 end-page: 2803 article-title: Preservation of pancreatic beta‐cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high‐risk hispanic women publication-title: Diabetes – volume: 368 start-page: 1696 year: 2006 end-page: 1705 article-title: The incretin system: glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in type 2 diabetes publication-title: Lancet – volume: 357 start-page: 28 year: 2007 end-page: 38 article-title: Rosiglitazone evaluated for cardiovascular outcomes – an interim analysis publication-title: N Engl J Med – volume: 27 start-page: 770 year: 2004 end-page: 774 article-title: Diabetes and oral tumors in Hungary. Epidemiological correlations publication-title: Diabetes Care – volume: 359 start-page: 2072 year: 2002 end-page: 2077 article-title: Acarbose for prevention of type 2 diabetes mellitus: the STOP‐NIDDM randomized trial publication-title: Lancet – volume: 346 start-page: 393 year: 2002 end-page: 403 article-title: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin publication-title: N Engl J Med – volume: 11 start-page: 293 year: 2005 end-page: 298 article-title: The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects publication-title: Oral Dis – volume: 290 start-page: 1884 year: 2003 end-page: 1890 article-title: Lifetime risk for diabetes mellitus in the United States publication-title: JAMA – volume: 28 start-page: 306 year: 2001 end-page: 310 article-title: The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus publication-title: J Clin Periodontol – volume: 43 start-page: 165 year: 2007 end-page: 173 article-title: Diabetes may increase risk for oral cancer through the insulin receptor substrate‐1 and focal adhesion kinase pathway publication-title: Oral Oncol – volume: 141 start-page: 421 year: 2004 end-page: 431 article-title: Meta‐analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus publication-title: Ann Intern Med – volume: 368 start-page: 1096 year: 2006 end-page: 1105 article-title: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial publication-title: Lancet – volume: 71 start-page: 1528 year: 2000 end-page: 1534 article-title: Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients publication-title: J Periodontol – volume: 27 start-page: 1265 year: 2004 end-page: 1270 article-title: Repaglinide versus nateglinide monotherapy: a randomized, multicenter study publication-title: Diabetes Care – volume: 67 start-page: 352 year: 1999 end-page: 360 article-title: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures publication-title: Ann Thorac Surg – volume: 354 start-page: 617 year: 1999 end-page: 621 article-title: Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe publication-title: Lancet – volume: 329 start-page: 977 year: 1993 end-page: 986 article-title: The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus publication-title: N Engl J Med – volume: 34 start-page: 46 year: 2007 end-page: 52 article-title: Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study publication-title: J Clin Periodontol – volume: 20 start-page: 537 year: 1997 end-page: 544 article-title: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study publication-title: Diabetes Care – volume: 344 start-page: 1343 year: 2001 end-page: 1350 article-title: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance publication-title: N Engl J Med – volume: 28 start-page: 2093 year: 2005 end-page: 2100 article-title: PRESERVE: two year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin publication-title: Diabetes Care – volume: 298 start-page: 194 year: 2007 end-page: 206 article-title: Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta‐analysis publication-title: JAMA – volume: 23 start-page: 9 year: 1974 end-page: 15 article-title: Impaired leukocyte function in patients with poorly controlled diabetes publication-title: Diabetes – volume: 74 start-page: 1361 year: 2003 end-page: 1367 article-title: Effect of non‐surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus publication-title: J Periodontol – volume: 16 start-page: 329 year: 1993 end-page: 334 article-title: Periodontal disease: the sixth complication of diabetes mellitus publication-title: Diabetes Care – volume: 28 start-page: 27 year: 2005 end-page: 32 article-title: Periodontal disease and mortality in type 2 diabetes publication-title: Diabetes Care – volume: 353 start-page: 2643 year: 2005 end-page: 2653 article-title: Intensive diabetes treatment and cardiovascular disease in patients with type 1 Diabetes. The DCCT / EDIC Study Research Group publication-title: N Engl J Med – volume: 345 start-page: 1359 year: 2001 end-page: 1367 article-title: Intensive insulin therapy in critically ill patients publication-title: N Engl J Med – volume: 1 start-page: CD002967 year: 2006 article-title: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus publication-title: Cochrane Database Syst Rev – volume: 31 start-page: 3 year: 2003 end-page: 23 article-title: The World Oral Health Report 2003: continuous improvement of oral health in the 21st century – the approach of the WHO Global Oral Health Programme publication-title: Community Dent Oral Epidemiol – volume: 355 start-page: 2427 year: 2006 end-page: 2443 article-title: Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy publication-title: N Engl J Med – volume: 67 start-page: 1085 year: 1996 end-page: 1093 article-title: Severe periodontitis and risk for poor glycemic control in patients with non‐insulin‐dependent diabetes mellitus publication-title: J Periodontol – volume: 30 start-page: 182 year: 2002 end-page: 192 article-title: Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population publication-title: Community Dent Oral Epidemiol – volume: 4 start-page: 37 year: 1998 end-page: 40 article-title: Prevalence of oral lichen planus in diabetes mellitus according to the type of diabetes publication-title: Oral Dis – volume: 287 start-page: 2563 year: 2002 end-page: 2569 article-title: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus publication-title: JAMA – volume: 352 start-page: 1425 year: 2005 end-page: 1435 article-title: Intensive lipid lowering with atorvastatin in patients with stable coronary disease publication-title: N Engl J Med – volume: 361 start-page: 2005 year: 2003 end-page: 2016 article-title: Heart Protection Collaborative Group. MRC / BHF Heart Protection Study of cholesterol‐lowering with simvastatin in 5963 people with diabetes: a randomised placebo‐controlled trial publication-title: Lancet – volume: 321 start-page: 412 year: 2000 end-page: 419 article-title: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study publication-title: BMJ – volume: 317 start-page: 703 year: 1998 end-page: 713 article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: (UKPDS 38) publication-title: BMJ – volume: 30 start-page: S4 year: 2007 end-page: S41 article-title: American Diabetes Association publication-title: Diabetes Care – volume: 69 start-page: 662 year: 2003 end-page: 662e article-title: A review of the functional and psychosocial outcomes of edentulousness treated with complete replacement dentures publication-title: J Can Dent Assoc – volume: 2 start-page: 173 year: 2007 end-page: 181 article-title: An update on insulin injection devices publication-title: Insulin – volume: 352 start-page: 837 year: 1998 end-page: 853 article-title: Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) publication-title: Lancet – volume: 29 start-page: 970 year: 2006 end-page: 975 article-title: A clinical screening tool identifies autoimmune diabetes in adults publication-title: Diabetes Care – volume: 80 start-page: 408 year: 2001b end-page: 413 article-title: The relationship among dental status, nutrient intake, and nutritional status in older people publication-title: J Dent Res – volume: 49 start-page: 304 year: 2007 end-page: 310 article-title: The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes: mediation by superoxide production, resolution with intensive insulin administration publication-title: J Am Coll Cardiol – volume: 86 start-page: 3257 year: 2001 end-page: 3265 article-title: Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti‐inflammatory effect? publication-title: J Clin Endocrinol Metab – volume: 46 start-page: 742 year: 1997 end-page: 749 article-title: Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine‐30, 50‐cyclic monophosphate and adenosine‐30, 50‐cyclic monophosphate publication-title: Diabetes – start-page: 797 year: 2004 end-page: 807 – volume: 18 start-page: 483 year: 2001 end-page: 488 article-title: Contraindications to metformin therapy in patients with Type 2 diabetes – a population‐based study of adherence to prescribing guidelines publication-title: Diabet Med – volume: 22 start-page: 233 year: 1999 end-page: 240 article-title: The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years publication-title: Diabetes Care – volume: 356 start-page: 2457 year: 2007 end-page: 2471 article-title: Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes publication-title: N Engl J Med – volume: 354 start-page: 617 year: 1999 ident: e_1_2_15_17_1 article-title: Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe publication-title: Lancet contributor: fullname: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group – ident: e_1_2_15_44_1 doi: 10.1034/j.1600-0528.2001.290305.x – ident: e_1_2_15_56_1 doi: 10.2337/diacare.27.3.770 – ident: e_1_2_15_50_1 doi: 10.1902/jop.1996.67.10s.1085 – ident: e_1_2_15_22_1 doi: 10.1111/j.1600-051X.2006.01002.x – ident: e_1_2_15_48_1 doi: 10.1034/j.1600-051x.2001.028004306.x – ident: e_1_2_15_38_1 doi: 10.1902/jop.2003.74.9.1361 – ident: e_1_2_15_51_1 doi: 10.1056/NEJM199309303291401 – volume: 1 start-page: CD002967 year: 2006 ident: e_1_2_15_41_1 article-title: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus publication-title: Cochrane Database Syst Rev contributor: fullname: Salpeter S – ident: e_1_2_15_21_1 doi: 10.1056/NEJMoa073394 – ident: e_1_2_15_31_1 doi: 10.1056/NEJMoa072761 – ident: e_1_2_15_7_1 doi: 10.2337/diabetes.51.9.2796 – ident: e_1_2_15_23_1 doi: 10.1056/NEJMoa066224 – ident: e_1_2_15_59_1 doi: 10.1056/NEJMoa011300 – ident: e_1_2_15_47_1 doi: 10.1172/JCI117433 – ident: e_1_2_15_18_1 doi: 10.1016/j.oraloncology.2006.02.004 – ident: e_1_2_15_6_1 doi: 10.2337/diab.23.1.9 – ident: e_1_2_15_32_1 doi: 10.2337/diacare.20.4.537 – ident: e_1_2_15_57_1 doi: 10.1111/j.1600-051X.1988.tb01003.x – ident: e_1_2_15_2_1 doi: 10.1136/bmj.321.7258.412 – ident: e_1_2_15_20_1 doi: 10.1016/S0140-6736(98)04311-6 – ident: e_1_2_15_19_1 doi: 10.1902/jop.1997.68.8.713 – ident: e_1_2_15_45_1 doi: 10.1177/00220345010800020201 – ident: e_1_2_15_9_1 doi: 10.1016/S0140-6736(03)13636-7 – ident: e_1_2_15_53_1 doi: 10.2337/diabetes.46.5.742 – ident: e_1_2_15_27_1 doi: 10.1902/jop.2000.71.10.1528 – ident: e_1_2_15_30_1 doi: 10.1056/NEJMoa052187 – ident: e_1_2_15_37_1 doi: 10.2337/diacare.29.03.06.dc05-1254 – ident: e_1_2_15_11_1 doi: 10.1210/jc.86.7.3257 – ident: e_1_2_15_8_1 doi: 10.1016/S0140-6736(02)08905-5 – ident: e_1_2_15_24_1 doi: 10.1056/NEJMoa012512 – ident: e_1_2_15_61_1 doi: 10.1001/jama.287.19.2563 – ident: e_1_2_15_10_1 doi: 10.2337/diacare.22.2.233 – ident: e_1_2_15_36_1 doi: 10.1111/j.1601-0825.2005.01119.x – ident: e_1_2_15_54_1 doi: 10.1034/j.1600-0528.2002.300304.x – ident: e_1_2_15_55_1 doi: 10.1056/NEJM200105033441801 – ident: e_1_2_15_3_1 doi: 10.1210/jc.87.3.1419 – ident: e_1_2_15_26_1 doi: 10.2337/diacare.16.1.329 – ident: e_1_2_15_33_1 doi: 10.1007/s00134-002-1628-4 – ident: e_1_2_15_12_1 doi: 10.1016/S0140-6736(06)69705-5 – volume: 368 start-page: 1096 year: 2006 ident: e_1_2_15_52_1 article-title: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(06)69420-8 contributor: fullname: The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone medication) Investigators – ident: e_1_2_15_40_1 doi: 10.2337/diacare.27.6.1265 – ident: e_1_2_15_15_1 doi: 10.1016/S0003-4975(99)00014-4 – ident: e_1_2_15_42_1 doi: 10.2337/diacare.28.1.27 – ident: e_1_2_15_35_1 doi: 10.1111/j.1601-0825.1998.tb00253.x – volume: 30 start-page: S4 year: 2007 ident: e_1_2_15_46_1 article-title: American Diabetes Association publication-title: Diabetes Care contributor: fullname: Standards of Medical Care in Diabetes – start-page: 797 volume-title: Diabetes mellitus: a fundamental and clinical text year: 2004 ident: e_1_2_15_49_1 contributor: fullname: Tataranni PA – ident: e_1_2_15_13_1 doi: 10.1046/j.1464-5491.2001.00509.x – ident: e_1_2_15_28_1 doi: 10.1016/S1557-0843(07)80061-3 – ident: e_1_2_15_39_1 doi: 10.2337/diacare.28.9.2130 – ident: e_1_2_15_60_1 doi: 10.1016/j.jacc.2006.08.053 – ident: e_1_2_15_16_1 doi: 10.2337/diacare.28.9.2093 – volume: 69 start-page: 662 year: 2003 ident: e_1_2_15_4_1 article-title: A review of the functional and psychosocial outcomes of edentulousness treated with complete replacement dentures publication-title: J Can Dent Assoc contributor: fullname: Allen PF – ident: e_1_2_15_25_1 doi: 10.1056/NEJMoa050461 – ident: e_1_2_15_14_1 doi: 10.2337/dc05-2101 – ident: e_1_2_15_34_1 doi: 10.1046/j..2003.com122.x – ident: e_1_2_15_43_1 doi: 10.7326/0003-4819-141-6-200409210-00007 – ident: e_1_2_15_29_1 doi: 10.1001/jama.290.14.1884 – ident: e_1_2_15_5_1 doi: 10.1001/jama.298.2.194 – volume: 317 start-page: 703 year: 1998 ident: e_1_2_15_58_1 article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: (UKPDS 38) publication-title: BMJ doi: 10.1136/bmj.317.7160.703 contributor: fullname: UK Prospective Diabetes Study (UKPDS) Group |
| SSID | ssj0017932 |
| Score | 2.1824098 |
| SecondaryResourceType | review_article |
| Snippet | Diabetes mellitus is a prevalent disease that affects millions of people worldwide and has paralleled the growing population of overweight and obese... |
| SourceID | proquest crossref pubmed wiley istex |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 105 |
| SubjectTerms | Blood Glucose - metabolism cardiovascular disease Cardiovascular Diseases - complications Cardiovascular Diseases - metabolism Dentistry Diabetes Complications - complications Diabetes Complications - metabolism Diabetes Complications - prevention & control diabetes mellitus Diabetes Mellitus - classification Diabetes Mellitus - metabolism Diabetes Mellitus - prevention & control Diabetes Mellitus - therapy Humans Mouth Diseases - complications Mouth Diseases - metabolism Mouth Diseases - prevention & control periodontitis |
| Title | Update on diabetes mellitus: prevention, treatment, and association with oral diseases |
| URI | https://api.istex.fr/ark:/67375/WNG-K51XFZ90-J/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1601-0825.2007.01425.x https://www.ncbi.nlm.nih.gov/pubmed/18302671 https://search.proquest.com/docview/70336415 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PT9swFH5CTGK7jME2VrYxHyZOpEqc2E52Q5TyY4JJiEK1i-WXOJdqaUVbCe2v33tJWijiME275eLEfn7P_t7zl88AX1VMfpCpMkhL5QLaIXyAiYsCLAtZlrk0shYwvbjUp4PkfKiGLf-J_4Vp9CGWBTeOjHq95gB3OF0Ncs2pMKU4rRJhRP7XZTwZxYbZXb2rpZIUu2F98BmrhHOv4Sqp59kXrexUL9jo98_B0FVUW29L_U0YLQbUsFFG3fkMu_nvJ1qP_2fEb-B1i17FYeNuW7Dmq2142WPGEV8atw0bF-1Z_Vu4GUy4miDGlVgUeMUvlv-czaffxKSVjhpXB2JJdj8QriqEe_AYwWViwSICoj1Jmr6DQf_4-ug0aG9xCHICgyrIiixSZagkYpobwh-acpS8kEnqpEcXJjmGSDihkJjrNI1i78tMoyq0zgyhofg9rFfjyn8AQQPHIkEZOjRJbjQSPEXpdVJExtBC1YFoMWN20oh12EdJDhnPsvH46k1ja-PZ-w7s11O7bODuRkx2M8reXp7Y7yoa9n9moT3vwJfF3FsKQT5XcZUfz6eWFs1Yk5t3YKdxiYePs7qaNtQxXU_sX_fK_uid8dPuvzb8CK8aZguz5T7B-uxu7j8TfJrhXh0YfwC12gjY |
| link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9tAEB4hkKAXyqMt4bmHihOO7LV31-4NEUJ4JJUQoVEvq117faE4EUkk1F_fGdsJDeJQod58WXt3Z2b3m4e_AfgqQtSDRORenAvj4Q3hPBuZwLN5xvM85YqXBKbdnuz0o6uBGNTtgOhfmIofYh5wI8soz2sycApIL1q5JF8YfZyaijBABWwioFxB6w-pj0Prds4lRYpYpj5DEZH3NVgs63nzTQt31Qpt-_NbQHQR15YXU_sj_JotqapHeWhOJ7aZ_n7F9vif1rwB6zWAZaeVxm3Ckiu2YK1FRUfUN24LVrt1un4b7vsjCiiwYcFmMV72SAygk-n4GxvV7FHD4oTN691PmCkyZl6UhlGkmBGPAKuTSeNP0G-f3511vLqRg5ciHhRekiWByH3BrY1ThRBEopuSZjyKDXfW-FFqfYtQIeM2lXEchM7libQikzJRCIjCz7BcDAu3AwwXbrPIct9YFaVKWkSoljsZZYFSeFY1IJiJTI8qvg79l5-Dm6dp86j7ptLl5unnBhyXsp0PME8PVO-mhP7Ru9DXIhi0fya-vmrA0Uz4Gq2QUiumcMPpWOO5GUrU9AZ8qXTi5eNEsCYVTkyWkv3nWenvrUt62n3vwCNY69x1b_TNZe96Dz5UhS5UPLcPy5OnqTtANDWxh6WV_AFORQzw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV05b9swFH4IEiDp0jTp5fQIh6JTZEgUD6lbUdfN0ThBUbdGF4IUqcWobMQ2EPTX9z1JduIiQxFk00KJfAf5vUMfAd7JFO0gl2WUldJGeEKEyAmbRK70vCwLrnlNYHo-UMdDcTqSo7b_if6FafghVgk38ox6vyYHn_py3ckVhcIY4rRMhAnaXxfx5JZQCIQJIH1bUUmRHdaVz1QKCr5G6109d75p7ajaIqlf34VD12FtfS71d2G8XFHTjjLuLuauW_z5h-zxYZb8BB638JV9bOxtDzZCtQ87PWo5olvj9mH7vC3WP4UfwymlE9ikYssML_tN_J_zxewDm7bcUZPqiK263Y-YrTyzNybDKE_MiEWAtaWk2TMY9j9__3Qctdc4RAWiQRnlPk9kGUvuXFZoBCAKg5TCc5FZHpyNReFih0DBc1eoLEvSEMpcOemVyjXCofQ5bFaTKrwEhgt3XjgeW6dFoZVDfOp4UMInWuNO1YFkqTEzbdg6zK0oB4VnSHh096Y2tfDMdQfe16pdDbBXY-p209L8HHwxZzIZ9X_lsTntwOFS9wZ9kAortgqTxczgrpkqtPMOvGhM4ubjRK-mNE5M1Yr971mZi94JPR3cd-AhbF_2-ubryeDsFTxqulyoc-41bM6vFuENQqm5e1v7yF8GxAuf |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Update+on+diabetes+mellitus%3A+prevention%2C+treatment%2C+and+association+with+oral+diseases&rft.jtitle=Oral+diseases&rft.au=Skamagas%2C+M&rft.au=Breen%2C+TL&rft.au=LeRoith%2C+D&rft.date=2008-03-01&rft.issn=1354-523X&rft.eissn=1601-0825&rft.volume=14&rft.issue=2&rft.spage=105&rft.epage=114&rft_id=info:doi/10.1111%2Fj.1601-0825.2007.01425.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1601_0825_2007_01425_x |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1354-523X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1354-523X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1354-523X&client=summon |